Sanofi's Dividends per Share for the
six
months ended in Jun. 2023 was $1.92.
The historical rank and industry rank for Sanofi's 3-Year Dividend Growth Rate or its related term are showing as below:
SNY'
s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -15.6 Med: 4.55 Max: 37.9
Current: 4.2
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Sanofi was 37.90% per year. The lowest was -15.60% per year. And the median was 4.55% per year.
SNY's 3-Year Dividend Growth Rate is ranked worse than 61.56% of 320
companies
in the Drug Manufacturers industry
Industry Median: 8.9
vs SNY: 4.20
During the past 12 months, Sanofi's average Dividends Per Share Growth Rate was 6.90% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 4.20% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 3.10% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 2.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
Sanofi SA stock dividend yield is close to 5-year high.
For more information regarding to dividend, please check our Dividend Page.
Competitive Comparison
For the Drug Manufacturers - General subindustry, Sanofi's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sanofi 3-Year Dividend Growth Rate Distribution
For the Drug Manufacturers industry and Healthcare sector, Sanofi's 3-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where Sanofi's 3-Year Dividend Growth Rate falls into.
Sanofi 3-Year Dividend Growth Rate Calculation
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest Dividend Payout Ratio of Sanofi was 0.82. The lowest was 0.45. And the median was 0.61.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Sanofi Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 1.900
2023-05-30
2023-05-31
2023-06-23
Cash Dividend
annually
USD:USD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Sanofi's Dividend Yield (%) for Today is calculated as
Current Share Price is $46.11.
Sanofi's Dividends per Share for the trailing twelve months (TTM) ended in Today is $1.9.
During the past 13 years, the highest Dividend Yield of Sanofi was 4.70%. The lowest was 2.84%. And the median was 3.66%.
Good Sign:
Sanofi SA stock dividend yield is close to 5-year high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 15% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SNY has been successfully added to your